The nurse should monitor the patient most closely for which … | 마이메르시 MyMerci
Adult Health
문제

The nurse should monitor the patient most closely for which potential complication following the administration of naloxone?

A 28-year-old patient was brought to the emergency department by paramedics after being found unconscious with suspected heroin overdose. The patient received 2 mg of naloxone IV and regained consciousness. Vital signs are now: BP 140/90 mmHg, HR 110 bpm, RR 16/min, O2 sat 94% on room air, temperature 98.6°F (37°C).
해설
The priority concern after naloxone administration is the return of respiratory depression as naloxone has a shorter half-life than most opioids, requiring continuous monitoring and possible re-dosing.

심화 해설

Core Nursing Explanation Key Concept Analysis: This question assesses the critical nursing priority after administering Naloxone, an opioid antagonist, for a suspected opioid overdose. The core concept is understanding the pharmacokinetic mismatch between naloxone and the opioid it is reversing. Naloxone has a relatively short duration of action (approximately 30-90 minutes), while opioids like heroin can have much longer-lasting effects. This creates a high-risk window where the opioid can re-bind to receptors once the naloxone wears off, leading to a recurrence of overdose symptoms.

Answer Rationale: Key Point! The nurse must monitor most closely for the return of respiratory depression and decreased level of consciousness. This is the most life-threatening complication. The patient's initial improvement is temporary, and vigilant, continuous monitoring of respiratory rate, depth, and mental status is essential for early detection of re-sedation. The half-life of naloxone is shorter than that of most opioids, meaning its protective effect may wear off before the opioid is fully metabolized.

Distractor Analysis: Watch out for confusion! Option ②, Hypertension and tachycardia, are common initial effects of naloxone administration as it rapidly reverses opioid-induced hypotension and bradycardia, leading to a catecholamine surge. However, in this stable post-administration phase, they are not the primary complication to monitor for.
Option ③, Nausea and vomiting, can occur as the opioid's antiemetic effect is reversed, but this is a less critical concern compared to airway and breathing.
Option ④, Agitation and restlessness, can be seen as part of acute opioid withdrawal precipitated by naloxone, but patient safety is prioritized over managing withdrawal symptoms. The imminent threat is respiratory failure, not agitation.

Related Concepts: This scenario integrates principles of emergency nursing, pharmacology, and the ABCs (Airway, Breathing, Circulation) of patient care. The nursing role extends beyond administration to vigilant monitoring for rebound toxicity. Understanding the concept of drug half-life and receptor kinetics is crucial for anticipating this complication.
Concept Summary
ConceptExplanation
Naloxone (Narcan)Opioid receptor antagonist. Competitively binds to opioid receptors, reversing CNS and respiratory depression.
Rebound Respiratory DepressionPrimary complication due to naloxone's shorter duration of action than the opioid. Requires close monitoring for 1-2+ hours.
Opioid Overdose TriadClassic signs: Respiratory depression, pinpoint pupils (miosis), and decreased level of consciousness.
Nursing Priority (ABCs)Airway, Breathing, Circulation. Monitoring respiratory status is always the top priority in overdose and reversal scenarios.

Side-by-Side Comparison!
Monitoring Focus After NaloxoneWhy It's Important / Not the Priority
Return of Respiratory DepressionPRIORITY: Life-threatening. Direct result of naloxone wearing off before the opioid is cleared.
Acute Withdrawal Symptoms (Agitation, N/V)Expected but secondary. Naloxone precipitates withdrawal; manage for safety and comfort but do not confuse with the primary threat.
Vital Sign Instability (HTN, Tachycardia)Common initial response. Monitor, but it's usually transient and less dangerous than apnea.

Anatomy, Physiology & Pharmacology Points
  • Mechanism of Action: Naloxone is a competitive antagonist at mu, kappa, and delta opioid receptors. It has a higher affinity for these receptors than opioids but does not activate them, thereby blocking the opioid's effect.
  • Pharmacokinetics: Onset: 1-2 minutes IV. Duration: 30-90 minutes. This is shorter than the duration of action of heroin (several hours) and other long-acting opioids like methadone.
  • Pathophysiology: Opioids suppress the brainstem's respiratory centers. Reversal is rapid, but if the antagonist level falls, the remaining opioid can re-suppress breathing.

Memory Tips
  • Mnemonic: "Short Stay, Long Threat" – Naloxone has a short stay in the body, but the opioid poses a long threat. Monitor until the threat is gone.
  • Clinical Pearl: Think of naloxone as a "temporary shield." The nurse's job is to watch for when the shield drops before the "attack" (opioid effect) is over.

High-Frequency NCLEX Topics This is a classic High-Yield pharmacology/safety question. The NCLEX-RN loves to test:
  1. Priority identification after medication administration.
  2. Application of pharmacokinetics (half-life, duration) to nursing care.
  3. Monitoring for the most dangerous complication, always tying back to Airway and Breathing.

Watch Out for Question Variations!
  • Shift in Focus: The question could ask for the first action (assess airway/breathing), the priority assessment (respiratory status), or the rationale for continuous monitoring (shorter half-life).
  • Different Setting: The same principle applies for naloxone given in pre-hospital settings, on medical-surgical floors for accidental opioid overdose, or via intranasal auto-injector (Narcan Nasal Spray).
  • Related Drug: Questions about Flumazenil (a benzodiazepine antagonist) test the same concept: monitor for return of sedation/respiratory depression due to its short duration.

임상 시나리오

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse in the ED. Your patient, J.D., is now awake after receiving naloxone for a heroin overdose. He is asking to leave. His respiratory rate is 16, but he appears slightly drowsy again 45 minutes later.

Nursing Intervention Strategy:
  1. Assessment: Continuously monitor respiratory rate, depth, rhythm, and oxygen saturation. Use a capnography if available for trend monitoring of end-tidal CO2. Perform frequent neurological checks (AVPU or Glasgow Coma Scale (GCS)).
  2. Planning/Implementation:
    • Keep resuscitation equipment (bag-valve-mask, suction) at the bedside.
    • Establish IV access and keep it patent.
    • Prepare a second dose of naloxone for potential administration. It may be given via IV push or as a continuous infusion for long-acting opioids.
    • Do not leave the patient unattended. Use sitters or frequent checks if the patient is in a room.
    • Provide calm, non-judgmental reassurance as the patient may experience distressing withdrawal symptoms.
  3. Patient Education & Evaluation: Educate the patient and family (if appropriate) on the risk of rebound sedation. Advocate for a mandatory observation period (often 2-4 hours minimum). Evaluate for readiness for discharge only after a sustained period of stability and a clear plan for follow-up, including substance use disorder resources.
Patient Safety and Precautions:
  • Contraindication: There are no absolute contraindications to naloxone in a life-threatening overdose situation.
  • Caution: Administer carefully to patients with known opioid dependence, as it will precipitate acute, severe withdrawal. The goal is to titrate to adequate respiration, not necessarily to full arousal.
  • Key Monitoring: The greatest risk period is 30 minutes to 2 hours post-administration, but monitor longer for long-acting opioids (e.g., methadone, sustained-release formulations).

Nursing Procedure & Medication Flow Naloxone Administration (IV Push) & Monitoring:
  1. Indication: Confirmed or suspected opioid overdose with respiratory depression/arrest.
  2. Action: Administer 0.4 mg - 2 mg IV push. May repeat every 2-3 minutes as needed. For continuous infusion, typical dilution is 2 mg in 500 mL NS, titrated to respiratory effort.
  3. Monitoring During/After:
    • During: Watch for rapid reversal: increased respirations, arousal, possible agitation.
    • After (Critical): Monitor respiratory status q15min x 1 hour, then q30min x 1-2 hours, then hourly based on facility policy and patient status. Document meticulously.
  4. Patient Positioning: Place patient in lateral recumbent position if decreased LOC to protect airway.

A Word from Your Senior Nurse "Remember, giving naloxone is like hitting the emergency brake – it stops the crash, but the car (the patient's body) still has momentum (the remaining opioid). Your expert nursing surveillance is what keeps the patient from crashing again after that initial save. In the ED, we see this often. That moment when a patient wakes up after naloxone is a relief, but it's not the end of your work. Your most important nursing action starts right then: watchful waiting and being ready to act. This mindset of anticipating complications based on pharmacology is what separates a task-completer from a life-saving nurse."

핵심 개념

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.